ART-induced toxicity has been frequently reported in HIV/HCV co-infected individuals. However, there is conflicting evidence on whether HCV co-infection has a synergistic effect on ART-induced toxicity. One way to evaluate this hypothesis is to compare the risk of alanine aminotransferase (ALT) elevation associated with the use of ART in HIV mono-infected versus HIV/ HCV co-infected populations.
Is ART use associated with increased risk of ALT elevation in HIV/HCV co-infeceted patients over and above what is expected in HIV mono-infected? A nested case-control analysis.
G. NunnariMembro del Collaboration Group
;G. F. Pellicanò.Membro del Collaboration Group
2016-01-01
Abstract
ART-induced toxicity has been frequently reported in HIV/HCV co-infected individuals. However, there is conflicting evidence on whether HCV co-infection has a synergistic effect on ART-induced toxicity. One way to evaluate this hypothesis is to compare the risk of alanine aminotransferase (ALT) elevation associated with the use of ART in HIV mono-infected versus HIV/ HCV co-infected populations.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.